Clinical research of dose - dense combinated pharmorubicin with paclitaxel in advanced breast cancer treatment / 重庆医科大学学报
Journal of Chongqing Medical University
; (12)2003.
Article
在 Zh
| WPRIM
| ID: wpr-574449
Responsible library:
WPRO
ABSTRACT
Purpose;To observe curative effect and side reaction ,histopathology change of dose - dense combinated pharmorubicin with paclitaxel in advanced breast cancer treatment. Methods ;38 patients with advanced breast cancer diagnosed by pathology, which had e-valuation index, pharmorubicin 50mg/m2 ,d1 , intravenous injection,paclitaxel 175mg/m2,d2,intravenous injection,every 2 weeks as 1 course of treatment,after accepted 2 - 4 course of treatment,all patients were evaluated.